The CD28-Related Molecule ICOS Is Required for Effective T Cell–Dependent Immune Responses-Reference-Cited by-同舟云学术

The CD28-Related Molecule ICOS Is Required for Effective T Cell–Dependent Immune Responses

Published:2000-07 Issue:1 Volume:13 Page:95-105
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Coyle Anthony J,Lehar Sophie,Lloyd Clare,Tian Jane,Delaney Tracy,Manning Stephen,Nguyen Trang,Burwell Tim,Schneider Helga,Gonzalo Jose Angel,Gosselin Michael,Owen Laura Rudolph,Rudd Christopher E,Gutierrez-Ramos Jose Carlos

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference49 articles.

1. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation;Bachmann;J. Exp. Med.,1999

2. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation;Borriello;Immunity,1997

3. A two-step, two-signal model for the primary activation of precursor helper T cells;Bretscher;Proc. Natl. Acad. Sci. USA,1999

4. Limited role of CD28-mediated signals in T helper subset differentiation;Brown;J. Exp. Med.,1996

5. OX40 ligand has a critical costimulatory role in dendritic cell:T cell interactions;Chen;Immunity,1999

Cited by 450 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy;Clinical Reviews in Allergy & Immunology;2024-07-12

2. MiR-155 -targeted IcosL controls tumor rejection;Proceedings of the National Academy of Sciences;2024-07-09

3. Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies;Exploration of Immunology;2024-04-02

4. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis;International Journal of Molecular Sciences;2024-02-21

5. Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy;Molecules;2024-01-17